Genomatica Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:$191.1M
Industry:Environmental
Founded:2000
Lead Investor(s):Casdin Capital
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Genomatica's estimated revenue is currently $33.2M per year.
  • Genomatica received $90.0M in venture funding in October 2018.
  • Genomatica's estimated revenue per employee is $196331
  • Genomatica's total funding is $191.1M.

Employee Data

  • Genomatica has 169 Employees.
  • Genomatica grew their employee count by 25% last year.
  • Genomatica currently has 5 job openings.

Executive Contacts

NameTitle
Damien PerrimanSenior Vice President, Specialty Chemicals
Nelson BartonVP Research/Development
Tae YangDirector of Systems Bioengineering
Priti PharkyaSenior Director, Strategy and Corporate Development
Joe KuterbachVP Operations and Technology Transfer
Lisa KennedyDirector Business Development
Michael JapsSenior Director, Process Technology
Bill BaumExecutive Chairman and Chief Business Development Officer
Benjamin GriffinProgram Director and Director, Enzyme Engineering
Itzel Ramos-SolisDirector, Strain Engineering

What Is Genomatica?

Genomatica is a widely-recognized technology leader for the chemical industry. We develop manufacturing processes that enable our licensee partners to produce the world's most widely-used chemicals a better way, from alternative feedstocks, with better economics and greater sustainability than petroleum-based processes. Genomatica has delivered the industry's first commercial biobased process for a high-volume intermediate chemical. Our GENO BDO process has produced thousands of tons of BDO and been licensed by BASF and Novamont. Multiple large chemical firms have publicly validated quality or described commercialization plans, including Invista (for its well-known Lycra® spandex), DSM, Lanxess, Toray, and Far Eastern New Century. Our biotechnology platform and over 500 patents and applications enable us to develop processes for additional major chemicals. The next is for butadiene, with Versalis and Braskem as partners, and over $100 million in industry support. We have also announced our program for nylon intermediates, including HMD, caprolactam and adipic acid. We've been honored to receive extensive recognition for our innovation, commercialization track record, and potential for broad impact. Recent examples include the Kirkpatrick Award, for the most noteworthy chemical engineering technology commercialized in the world, and the 2015 World Economic Forum Technology Pioneer award. See current job openings at www.genomatica.com/about/careers.

keywords:Biotechnology,Cleantech,Energy,Food & Beverages,Healthcare,Pharmaceuticals,Solar Power,Wind Power

169

Number of Employees

$33.2M

Revenue (est)

5

Current Jobs

25%

Employee Growth %

$191.1M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Forensic Analyt...
$27.1M1388%
Partner Energy
$9.2M47-2%
AEI Consultants
$68.9M3515%
3Degrees Group
$37.8M1933%
Natron Energy
$8.6M447%
Canadian Solar ...
$217.6M11093%
San Diego Count...
$11.3M5812%
Stillwater Scie...
$14.9M766%
sonnen
$21.2M10824%
Sierra Energy
$12.8M65-7%

Genomatica News

06/06/2019 - Bioengineering Company Genomatica Is Acquiring Assets From Biodiesel Firm To Expand Product Lines

Genomatica, which uses bacteria to manufacture chemicals from plants, announced Thursday that it is acquiring assets from the REG Life ...

06/06/2019 - Genomatica Acquires REG Life Sciences’ Assets

Adds capabilities to meet increasing demand for sustainable products. SAN DIEGO, June 06, 2019 (GLOBE NEWSWIRE) -- Genomatica, ...

06/06/2019 - Renewable Energy Group Completes Sale of REG Life ...

“We are pleased to be selling our Life Sciences' assets to Genomatica, who are well positioned to build upon the technical progress we have ...

Genomatica Funding

DateAmountRoundLead InvestorsReference
2010-03-29$15.0MCTPG BiotechArticle
2000-03-02$45.0MUndisclosedVantagePoint Venture PartnersArticle
2011-03-02$45.0MUndisclosedVantagePoint Venture PartnersArticle
2012-08-03$41.5MUndisclosedArticle
2014-03-10$6.8MUndisclosedArticle
2018-10-04$90.0MUndisclosedCasdin CapitalArticle

Genomatica Executive Hires

DateNameTitleReference
2010-09-14Bill BaumChairman/Chief Business Development OfArticle
2011-07-19Michael E. KeaneEVP/CFOArticle
2012-05-01Jeff LievenseEVP Process TechnologyArticle